Premium
Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia
Author(s) -
Ross David M.,
Pagani Ilaria S.,
Irani Yazad D.,
Clarson Jade,
Leclercq Tamara,
Dang Phuong,
McLean Jennifer,
Saunders Verity A.,
Carne Lisa,
Reynolds John,
Ritchie David S.,
White Deborah L.,
Branford Susan,
Hughes Timothy P.,
Yong Agnes S. M.
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15894
Subject(s) - medicine , lenalidomide , imatinib , discontinuation , imatinib mesylate , oncology , multiple myeloma , immunology , myeloid leukemia
David M. Ross, Ilaria S. Pagani, Yazad D. Irani, Jade Clarson, Tamara Leclercq, Phuong Dang, Jennifer McLean, Verity A. Saunders, Lisa Carne, John Reynolds, David S. Ritchie, Deborah L. White, Susan Branford, Timothy P. Hughes, Agnes S. M. Yong